The IHC staining results confirmed the correlations between LGALS8, RAB17 and EpCAM and survival of renal carcinoma patients treated with sunitinib, while CD9 failed to achieve significant discriminatory potential. This evidence concerns the gene RAB17 and renal carcinoma.